Cardiovascular disease (CV) is the most common cause of premature mortality in patients
with rheumatoid arthritis (RA). This is the result of an accelerated atherosclerotic process …

Metabolic syndrome (MetS) is a cluster of metabolic and cardiovascular (CV) risk factors
including obesity and visceral adiposity, insulin resistance, dyslipidemia and hypertension …

With the growing awareness of the impact of chronic back pain and axial spondyloarthritis
and recent breakthroughs in genetics and the development of novel treatments which may …

Introduction Patients with axial spondyloarthritis (axSpA) have a high disease burden mainly
due to the rheumatic disease itself, and also exhibit accelerated atherosclerosis, that leads …

Abstract Purpose of Review Diffuse Idiopathic Skeletal Hyperostosis (DISH) is considered a
metabolic condition, characterized by new bone formation affecting mainly at entheseal …

The term axial spondyloarthritis (axSpA) encompasses a heterogeneous group of diseases
that have variable presentations, extra-articular manifestations and clinical outcomes, and …

Ankylosing Spondylitis (AS) is a chronic inflammatory disorder of the spine and sacroiliac
joints with unidentified etiology closely associated with metabolic syndrome (MetS). Recent …

Biomarkers of the metabolic syndrome are divided into four subgroups. Although dividing
them in groups has some limitations, it can be used to draw some conclusions. In a first part …

Spondyloarthritis is a group of immune-mediated rheumatic disorders that significantly
impact patients' physical function and quality of life. Patients with spondyloarthritis …

In addition to β-cell failure with inadequate insulin secretion, the crucial mechanism leading
to establishment of diabetes mellitus (DM) is the resistance of target cells to insulin, ie insulin …